Acadia Pharmaceuticals Inc financial data

Symbol
ACAD on Nasdaq
Industry
Pharmaceutical Preparations
Location
12830 El Camino Real, Suite 400, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 222 % -17.2%
Quick Ratio 22.1 % +166%
Debt-to-equity 75.7 % +17.6%
Return On Equity 25.8 %
Return On Assets 14.7 %
Operating Margin -10.1 % +76.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 166M shares +1.35%
Common Stock, Shares, Outstanding 166M shares +1.45%
Entity Public Float 2.9B USD +70.6%
Common Stock, Value, Issued 16K USD 0%
Weighted Average Number of Shares Outstanding, Basic 166M shares +1.06%
Weighted Average Number of Shares Outstanding, Diluted 166M shares +1.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 726M USD +40.4%
Revenue from Contract with Customer, Excluding Assessed Tax 929M USD +47.1%
Research and Development Expense 269M USD -25.3%
Costs and Expenses 817M USD +3.91%
Operating Income (Loss) 112M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 137M USD
Income Tax Expense (Benefit) 8.19M USD -52.3%
Net Income (Loss) Attributable to Parent 129M USD
Earnings Per Share, Basic 0.78 USD/shares
Earnings Per Share, Diluted 0.78 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 155M USD +58%
Accounts Receivable, after Allowance for Credit Loss, Current 98.2M USD +5.83%
Inventory, Net 86.7M USD +242%
Assets, Current 788M USD +57.9%
Property, Plant and Equipment, Net 3.99M USD -18.3%
Operating Lease, Right-of-Use Asset 44.3M USD -12.8%
Other Assets, Noncurrent 359K USD -24.4%
Assets 977M USD +54.4%
Accounts Payable, Current 19.1M USD +55%
Employee-related Liabilities, Current 37M USD +8.38%
Accrued Liabilities, Current 325M USD +64.7%
Liabilities, Current 344M USD +64.1%
Deferred Income Tax Liabilities, Net 12.4M USD -6.34%
Operating Lease, Liability, Noncurrent 40.4M USD -16%
Other Liabilities, Noncurrent 15.3M USD +21%
Liabilities 400M USD +47.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 858K USD
Retained Earnings (Accumulated Deficit) -2.35B USD +5.19%
Stockholders' Equity Attributable to Parent 577M USD +59.4%
Liabilities and Equity 977M USD +54.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 29.1M USD
Net Cash Provided by (Used in) Financing Activities 1.04M USD -28.9%
Net Cash Provided by (Used in) Investing Activities -14M USD -107%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 166M shares +1.45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 16.1M USD -90.9%
Deferred Tax Assets, Valuation Allowance 482M USD +0.18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 494M USD +0.01%
Operating Lease, Liability 49.4M USD -13.6%
Depreciation 242K USD -43.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 130M USD
Lessee, Operating Lease, Liability, to be Paid 56.4M USD -15.3%
Property, Plant and Equipment, Gross 14.2M USD +0.35%
Operating Lease, Liability, Current 8.95M USD -0.91%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.97M USD -14.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.76M USD -5.04%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.07M USD -25.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.11M USD -6.46%
Deferred Tax Assets, Operating Loss Carryforwards 149M USD -34%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 37.1M USD +94.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.34M USD -0.29%
Operating Lease, Payments 10.1M USD +8.22%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.29M USD
Deferred Tax Assets, Net of Valuation Allowance 6.8M USD +467%
Share-based Payment Arrangement, Expense 74.6M USD +18.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%